Carrolee Barlow

Dr. Carrolee Barlow is an Independent Director at Supernus, Inc., an Independent Director at Supernus Pharmaceuticals, Inc. and a Chairman-Scientific Advisory Board at Fascinate Therapeutics , Inc. She is on the Board of Directors at Supernus, Inc. and Supernus Pharmaceuticals, Inc. Dr. Barlow was previously employed as a Chief Medical Officer by Arialys Therapeutics, Inc., an Independent Director by Orphazyme A/S, a Chief Medical Officer by ESCAPE Bio, Inc., a Chief Executive Officer & Director by Parkinson's Institute & Clinical Center, a Chief Scientific Officer by BrainCells, Inc., a Chief Medical Officer by Amicus Therapeutics, Inc., a Director-Molecular Neuroscience by Merck Research Laboratories Massachusetts LLC, and a Professor by The Salk Institute for Biological Studies.
She received her undergraduate degree from the University of Utah, a doctorate degree from the University of Utah School of Medicine and a doctorate degree from Karolinska Institutet.